Methods: (a) use of a SCFblocking antibody K44.2 (SCF-block, Sigma Aldrich
Solutions: (a) use of a SCFblocking antibody K44.two (SCF-block, Sigma Aldrich, St. Louis, MO), a human-specific antibody that binds extracellularly to KIT and prevents SCF-induced dimerization; (b)Cancer Res. Author manuscript;…